News
June 29, 2020 News
Oblique Therapeutics and Targovax enter collaboration
to target mutant RAS cancers by combining their ONCOS and Abiprot™ platforms.
June 11, 2020 News
Oblique Therapeutics AB has identified
a potentially important epitope for generation of SARS-CoV-2 antibodies.
June 4, 2020 News
General Meeting 2020
Oblique Therapeutics AB – Notice to the annual general meeting 2020.
November 27, 2019 News
Notice convening the Extraordinary
General Meeting on December 6 at 2pm.
October 24, 2019 Event
Oblique will be presenting at the RAS-Targeted
Drug Discovery Europe Summit in February.
October 10, 2019 News
Oblique Therapeutics is on EU-Startups top 10 list
-“10 European biotech startups to look out for in 2019 and beyond”.
July 17, 2019 News
We are proud to have been recognised
by StartUp City Magazine as one of the most promising European Biotech startups in 2019!